Market Overview:
The global needleless syringe market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for needle-free drug delivery devices, and technological advancements in the field of needleless syringes. Based on type, the global needleless syringe market is segmented into jet injectors, inhaler technology, transdermal patch, and novel needle free technologies. The jet injectors segment is expected to grow at a CAGR of 8.0% from 2018 to 2030 due to its advantages such as ease of use and reduced risk of infection as compared with traditional needles. Based on application, the global needleless syringe market is segmented into vaccine delivery, pain management, insulin delivery for diabetes mellitus patients (DM), pediatric injections (0-6 years), and other applications (such as ophthalmic injections). The vaccine delivery application segment is expected to grow at a CAGR of 7.8% from 2018to 2030 due its advantages such as increased patient compliance and reduced riskof infection .
Product Definition:
A needleless syringe is a medical device that allows the injection of fluid without the use of a needle. It consists of a chamber into which the fluid is injected, and an outlet through which it is expelled. The outlet may be fitted with a nozzle or other means of controlling the flow rate and direction of the fluid.
Jet Injectors:
Jet injectors are used to inject a drug at the target site with minimum wastage. It works by accelerating the flow of liquid through a narrow opening and injecting the drug at an angle, which reduces injection force and increases accuracy. The device is widely used in medical procedures such as chemotherapy, where it helps in delivering medication to intravenous patients without drawing blood.
The global jet injectors market size was valued at USD 673 million in 2016.
Inhaler Technology:
Inhaler technology is the latest and most effective way to deliver asthma medication. It uses a small, battery-powered machine that delivers medicine by inhalation through a plastic mask. The medicine is then absorbed by the lungs and transported to the bloodstream where it reaches its destination in minutes.
Application Insights:
The global needleless syringe market is segmented by application into vaccine delivery, pain management, insulin delivery for diabetes, pediatric injections and others. The vaccine delivery segment dominated the overall market in terms of revenue share in 2017. This can be attributed to the growing demand for immunization against a number of infectious diseases that affect humans globally. Moreover, technological advancements and new product launches are further expected to drive the growth of this segment over the forecast period. For instance, jet injectors have been introduced recently with improved performance characteristics which may result in increased adoption across various applications during future years.
The pain management segment is anticipated to exhibit lucrative growth over the forecast period owing to increasing adoption across medical procedures as well as rising awareness regarding better treatment options through needleless technologies such as jet injectors.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing government initiatives for developing novel needle-free technologies and supportive regulations framed by various regulatory authorities. For instance, in December 2016, the U.S FDA approved AUGMENT Needleless Injector from Bioject Inc., which is a jet injector technology used for insulin delivery for diabetes patients’ care.
In addition, increasing investments by governments of emerging economies are also contributing towards growth of this regional market (e.g., Japan has invested around USD X million on development of an automated insulin delivery system).
Growth Factors:
- Increasing demand for needleless syringes due to rising awareness about the benefits of using them over traditional needles.
- Growing number of syringe users in the healthcare sector, as they are more accurate and cause less pain than traditional needles.
- Rising demand for disposable needleless syringes from the pharmaceutical and biotechnology industries due to their safety and hygiene features.
- Technological advancements in needleless syringe design and manufacturing that have made them more user-friendly and reliable.
Scope Of The Report
Report Attributes
Report Details
Report Title
Needleless Syringe Market Research Report
By Type
Jet Injectors, Inhaler Technology, Transdermal Patch, Novel Needle Free Technologies
By Application
Vaccine Delivery, Pain Management, Insulin Delivery for Diabetes, Pediatric Injections
By Companies
Portal Instruments, 3M, BD, B. Braun Medical, Medline Industries, Inc., Antares Pharma, Inc., Injex Pharma AG, PharmaJet, Zogenix, Inc., BioJect Medical Technologies, Penjet Corporation, Valeritas, Akra Dermojet, Eternity Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Needleless Syringe Market Report Segments:
The global Needleless Syringe market is segmented on the basis of:
Types
Jet Injectors, Inhaler Technology, Transdermal Patch, Novel Needle Free Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaccine Delivery, Pain Management, Insulin Delivery for Diabetes, Pediatric Injections
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Portal Instruments
- 3M
- BD
- B. Braun Medical
- Medline Industries, Inc.
- Antares Pharma, Inc.
- Injex Pharma AG
- PharmaJet
- Zogenix, Inc.
- BioJect Medical Technologies
- Penjet Corporation
- Valeritas
- Akra Dermojet
- Eternity Healthcare
Highlights of The Needleless Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Jet Injectors
- Inhaler Technology
- Transdermal Patch
- Novel Needle Free Technologies
- By Application:
- Vaccine Delivery
- Pain Management
- Insulin Delivery for Diabetes
- Pediatric Injections
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Needleless Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A needleless syringe is a medical device that uses a plunger to dispense medications. It is often used to administer injections, such as those for chemotherapy or other treatments.
Some of the major players in the needleless syringe market are Portal Instruments, 3M, BD, B. Braun Medical, Medline Industries, Inc., Antares Pharma, Inc., Injex Pharma AG, PharmaJet, Zogenix, Inc., BioJect Medical Technologies, Penjet Corporation, Valeritas, Akra Dermojet, Eternity Healthcare.
The needleless syringe market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Needleless Syringe Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Needleless Syringe Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Needleless Syringe Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Needleless Syringe Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Needleless Syringe Market Size & Forecast, 2018-2028
4.5.1 Needleless Syringe Market Size and Y-o-Y Growth
4.5.2 Needleless Syringe Market Absolute $ Opportunity
Chapter 5 Global Needleless Syringe Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Needleless Syringe Market Size Forecast by Type
5.2.1 Jet Injectors
5.2.2 Inhaler Technology
5.2.3 Transdermal Patch
5.2.4 Novel Needle Free Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Needleless Syringe Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Needleless Syringe Market Size Forecast by Applications
6.2.1 Vaccine Delivery
6.2.2 Pain Management
6.2.3 Insulin Delivery for Diabetes
6.2.4 Pediatric Injections
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Needleless Syringe Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Needleless Syringe Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Needleless Syringe Analysis and Forecast
9.1 Introduction
9.2 North America Needleless Syringe Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Needleless Syringe Market Size Forecast by Type
9.6.1 Jet Injectors
9.6.2 Inhaler Technology
9.6.3 Transdermal Patch
9.6.4 Novel Needle Free Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Needleless Syringe Market Size Forecast by Applications
9.10.1 Vaccine Delivery
9.10.2 Pain Management
9.10.3 Insulin Delivery for Diabetes
9.10.4 Pediatric Injections
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Needleless Syringe Analysis and Forecast
10.1 Introduction
10.2 Europe Needleless Syringe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Needleless Syringe Market Size Forecast by Type
10.6.1 Jet Injectors
10.6.2 Inhaler Technology
10.6.3 Transdermal Patch
10.6.4 Novel Needle Free Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Needleless Syringe Market Size Forecast by Applications
10.10.1 Vaccine Delivery
10.10.2 Pain Management
10.10.3 Insulin Delivery for Diabetes
10.10.4 Pediatric Injections
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Needleless Syringe Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Needleless Syringe Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Needleless Syringe Market Size Forecast by Type
11.6.1 Jet Injectors
11.6.2 Inhaler Technology
11.6.3 Transdermal Patch
11.6.4 Novel Needle Free Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Needleless Syringe Market Size Forecast by Applications
11.10.1 Vaccine Delivery
11.10.2 Pain Management
11.10.3 Insulin Delivery for Diabetes
11.10.4 Pediatric Injections
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Needleless Syringe Analysis and Forecast
12.1 Introduction
12.2 Latin America Needleless Syringe Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Needleless Syringe Market Size Forecast by Type
12.6.1 Jet Injectors
12.6.2 Inhaler Technology
12.6.3 Transdermal Patch
12.6.4 Novel Needle Free Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Needleless Syringe Market Size Forecast by Applications
12.10.1 Vaccine Delivery
12.10.2 Pain Management
12.10.3 Insulin Delivery for Diabetes
12.10.4 Pediatric Injections
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Needleless Syringe Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Needleless Syringe Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Needleless Syringe Market Size Forecast by Type
13.6.1 Jet Injectors
13.6.2 Inhaler Technology
13.6.3 Transdermal Patch
13.6.4 Novel Needle Free Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Needleless Syringe Market Size Forecast by Applications
13.10.1 Vaccine Delivery
13.10.2 Pain Management
13.10.3 Insulin Delivery for Diabetes
13.10.4 Pediatric Injections
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Needleless Syringe Market: Competitive Dashboard
14.2 Global Needleless Syringe Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Portal Instruments
14.3.2 3M
14.3.3 BD
14.3.4 B. Braun Medical
14.3.5 Medline Industries, Inc.
14.3.6 Antares Pharma, Inc.
14.3.7 Injex Pharma AG
14.3.8 PharmaJet
14.3.9 Zogenix, Inc.
14.3.10 BioJect Medical Technologies
14.3.11 Penjet Corporation
14.3.12 Valeritas
14.3.13 Akra Dermojet
14.3.14 Eternity Healthcare
